Evercore ISI Lowers its Price Target on Jasper Therapeutics (JSPR) to $7

Jasper Therapeutics, Inc. (NASDAQ:JSPR) is one of the 8 Most Oversold Penny Stocks to Buy Right Now.

On April 1, 2026, Evercore ISI lowered the price target on Jasper Therapeutics, Inc. (NASDAQ:JSPR) to $7 from $12 and maintained an Outperform rating. Evercore ISI said the adjustment reflects updates across its small-to-mid cap biotechnology coverage as it reviewed Q2 catalysts, while noting stocks in the group are trading more on longer-horizon theses and broader FY26 catalysts.

On March 31, 2026, CEO Jeet Mahal said briquilimab has a “compelling and differentiated profile” in CSU and CIndU, with proof of concept in asthma, highlighting data from the BEACON study and open-label extension showing rapid and durable disease control. Jeet Mahal added that the company is finalizing dose selection for a Phase 2b/3 study in CSU and expects to begin patient enrollment in the second half of 2026, pending capital availability.

Evercore ISI Lowers its Price Target on Jasper Therapeutics (JSPR) to $7

Photo from Iovance Biotherapeutics website

On March 23, 2026, UBS initiated coverage on Jasper Therapeutics with a Neutral rating and a $1.50 price target. UBS said the stock presents a balanced risk-reward over the next 12 months, citing competitive uncertainties while noting dose optimization data could provide upside.

Jasper Therapeutics, Inc. (NASDAQ:JSPR) develops therapeutics targeting mast and hematopoietic stem cell-driven diseases.

While we acknowledge the risk and potential of JSPR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than JSPR and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.